Company intelligence
SOPHiA GENETICS
Democratizing Data-Driven Medicine, Together!
About SOPHiA GENETICS
SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.
Verified activity
Signals from SOPHiA GENETICS
10 published signals
Partnerships
SOPHiA GENETICS collaborated with the Hreditary Cancer Unit at Hospital Universitario 12 de Octubre for nearly 10 years to support diagnostic and research activities.
Reported by SOPHiA GENETICS
Presence & Recognition
SOPHiA GENETICS participated in Day 1 of the CBGM conference in São Luís, Brazil, with Booth #20 featuring an interactive demo of SOPHiA DDM™ for variant interpretation.
Reported by SOPHiA GENETICS
People
SOPHiA GENETICS CEO Callum Buxton stepped into the role after wrapping his fourth company-wide Ask-Me-Anything since stepping into the role in July.
Reported by Callum Buxton
Partnerships
SOPHiA GENETICS partnered with Hospital Sirio Libanés and Memorial Sloan Kettering Cancer Center to build a pilot clinical depth for the Pan-American Cancer Consortium in Brazil's SUS system.
Reported by Ross Muken
Presence & Recognition
SOPHiA GENETICS is hosting an Open Doors event on 15 October at the Rolle location to showcase cutting-edge technology and career opportunities.
Reported by SOPHiA GENETICS
Presence & Recognition
SOPHiA GENETICS and AstraZeneca are attending the ECP2026 industry symposium on 14 September at Room K21.
Reported by SOPHiA GENETICS
Research & Knowledge
SOPHiA GENETICS published real-world evidence showing nearly 4,800 patients across Spain accessing HRD testing without sending samples to a single lab.
Reported by Jurgi Camblong
Presence & Recognition
SOPHiA GENETICS biopharma team is joining the Society for Immunotherapy of Cancer (SITC) EU 2026 in Lausanne this week.
Reported by SOPHiA GENETICS
Presence & Recognition
SOPHiA GENETICS is participating in the Experts’ Panel of the Speed Networking session during the Career Workshops organized by European Conference on Computational Biology on Wednesday, September 2.
Reported by Jurgi Camblong
Research & Knowledge
SOPHiA GENETICS published exploratory research in Clinical Cancer Research examining how integrated analysis of clinical, genomic, and biomarker data supports understanding of patient heterogeneity in advanced solid tumors treated with combination immunotherapy.
Reported by Julien Pontis